RCMI Coordinating Center (RCMI CC) Header Logo

Connection

David Calhoun to 11-beta-Hydroxysteroid Dehydrogenase Type 2

Back to Details
This is a "connection" page, showing publications David Calhoun has written about 11-beta-Hydroxysteroid Dehydrogenase Type 2.
David Calhoun
Connection Strength
0.599
11-beta-Hydroxysteroid Dehydrogenase Type 2
  1. Ghazi L, Dudenbostel T, Hachem ME, Siddiqui M, Lin CP, Oparil S, Calhoun DA. 11-Beta Dehydrogenase Type 2 Activity Is Not Reduced in Treatment Resistant Hypertension. Am J Hypertens. 2017 May 01; 30(5):518-523.
    View in: PubMed
    Score: 0.599
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support